Cargando…

Comment on “Endothelial Protein C Receptor (EPCR), Protease Activated Receptor-1 (PAR-1) and Their Interplay in Cancer Growth and Metastatic Dissemination” Cancers 2019, 11, 51

Detalles Bibliográficos
Autores principales:	Pontarollo, Giulia, Melzow, Florentina, Reinhardt, Christoph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468748/ https://www.ncbi.nlm.nih.gov/pubmed/30884838 http://dx.doi.org/10.3390/cancers11030374

Ejemplares similares

Endothelial Protein C Receptor (EPCR), Protease Activated Receptor-1 (PAR-1) and Their Interplay in Cancer Growth and Metastatic Dissemination
por: Wojtukiewicz, Marek Z., et al.
Publicado: (2019)

The APC-EPCR-PAR1 axis in sickle cell disease
por: Ramadas, Nirupama, et al.
Publicado: (2023)

EPCR-PAR1 biased signaling regulates perfusion recovery and neovascularization in peripheral ischemia
por: Bochenek, Magdalena L., et al.
Publicado: (2022)

Protease-activated receptor-1 (PAR-1): a promising molecular target for cancer
por: Liu, Xuan, et al.
Publicado: (2017)

Protease-activated receptor (PAR)-2 is required for PAR-1 signalling in pulmonary fibrosis
por: Lin, Cong, et al.
Publicado: (2015)

Editorial Comment to Progressive plasmacytoid variant bladder cancer with retroperitoneal dissemination: An autopsy case report
por: Hayashi, Tetsutaro, et al.
Publicado: (2020)

Histone 2B Facilitates Plasminogen-Enhanced Endothelial Migration through Protease-Activated Receptor 1 (PAR1) and Protease-Activated Receptor 2 (PAR2)
por: Das, Mitali, et al.
Publicado: (2022)

Haplotypes of the endothelial protein C receptor (EPCR) gene are not associated with severe malaria in Tanzania
por: Hansson, Helle Holm, et al.
Publicado: (2015)

Protease-activated receptors (PARs)—biology and role in cancer invasion and metastasis
por: Wojtukiewicz, Marek Z., et al.
Publicado: (2015)

The H3 Haplotype of the EPCR Gene Determines High sEPCR Levels in Critically Ill Septic Patients
por: Vassiliou, Alice G., et al.
Publicado: (2018)

EPCR promotes MGC803 human gastric cancer cell tumor angiogenesis in vitro through activating ERK1/2 and AKT in a PAR1-dependent manner
por: Wang, Qingling, et al.
Publicado: (2018)

Identification of a broad lipid repertoire associated to the endothelial cell protein C receptor (EPCR)
por: Erausquin, Elena, et al.
Publicado: (2022)

Role of protease‐activated receptor‐1 (PAR‐1) in the glomerular filtration barrier integrity
por: Medipally, Ajay, et al.
Publicado: (2022)

Soluble endothelial protein C receptor (sEPCR) is likely a biomarker of cancer-associated hypercoagulability in human hematologic malignancies
por: Ducros, Elodie, et al.
Publicado: (2012)

EPCR promotes breast cancer progression by altering SPOCK1/testican 1-mediated 3D growth
por: Perurena, Naiara, et al.
Publicado: (2017)

Endothelial microparticles released by activated protein C protect beta cells through EPCR/PAR1 and annexin A1/FPR2 pathways in islets
por: Kreutter, Guillaume, et al.
Publicado: (2017)

Is ALDH1L1 Elevated in Lung Cancer? Comment on: Lee, S.-H.; et al. “The Combination of Loss of ALDH1L1 Function and Phenformin Treatment Decreases Tumor Growth in KRAS-Driven Lung Cancer” Cancers 2020, 12, 1382
por: Krupenko, Sergey A., et al.
Publicado: (2021)

Developmental Role of Zebrafish Protease-Activated Receptor 1 (PAR1) in the Cardio-Vascular System
por: Ellertsdottir, Elin, et al.
Publicado: (2012)

Comment on “ILC1 drive intestinal epithelial and matrix remodeling”
por: Hariss, Fatima, et al.
Publicado: (2021)

Comments on Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease by Dai et al.(2020)
por: Chiappelli, Francesco
Publicado: (2020)

Humanizing the Protease-Activated Receptor (PAR) Expression Profile in Mouse Platelets by Knocking PAR1 into the Par3 Locus Reveals PAR1 Expression Is Not Tolerated in Mouse Platelets
por: French, Shauna L., et al.
Publicado: (2016)

Predictive value of protease‐activated receptor‐2 (PAR(2)) in cervical cancer metastasis
por: He, Shengnan, et al.
Publicado: (2020)

The multifaceted protease-anti-protease imbalance in COVID-19
por: Goel, Khushboo, et al.
Publicado: (2022)

Complement factor C4a does not activate protease‐activated receptor 1 (PAR1) or PAR4 on human platelets
por: Han, Xu, et al.
Publicado: (2020)

Comment
por: Ring, Tim
Publicado: (2020)

Comment
por: Ring, Tim
Publicado: (2020)

Comment
por: Ring, Tim
Publicado: (2021)

Protease activated receptor 1 (PAR1) enhances Src-mediated tyrosine phosphorylation of NMDA receptor in intracerebral hemorrhage (ICH)
por: Duan, Zhen-Zhen, et al.
Publicado: (2016)

Potential importance of protease activated receptor (PAR)-1 expression in the tumor stroma of non-small-cell lung cancer
por: Lin, Cong, et al.
Publicado: (2017)

Endothelial Protein C Receptor gene Expression in a Female with Homozygous EPCR gene 23-bp Insertion
por: Karabıyık, Afife, et al.
Publicado: (2012)

The Effects of Endothelial Protein C Receptor Gene Polymorphisms on the Plasma sEPCR Level in Venous Thrombosis Patients
por: Karabıyık, Afife, et al.
Publicado: (2012)

Clinical significance of serum Protease-Activated Receptor-1 (PAR-1) levels in patients with cutaneous melanoma
por: Tas, Faruk, et al.
Publicado: (2016)

Pleiotropic Effects of the Protease-Activated Receptor 1 (PAR1) Inhibitor, Vorapaxar, on Atherosclerosis and Vascular Inflammation
por: Friebel, Julian, et al.
Publicado: (2021)

A role for interleukin-1 receptor antagonism in severe COVID-19?
por: Tattersall, Rachel S, et al.
Publicado: (2021)

ALPK1: a pattern recognition receptor for bacterial ADP-heptose
por: Cong, Yingzi
Publicado: (2018)

Comment on McCarthy, C.; et al. Developing Picornaviruses for Cancer Therapy. Cancers 2019, 11, 685
por: Alberts, Pēteris
Publicado: (2020)

EDITOR'S COMMENT
por: Vaidya, Rama, et al.
Publicado: (2010)

How the glucocorticoid receptor contributes to platinum-based therapy resistance in solid cancer
por: Clarisse, Dorien, et al.
Publicado: (2021)

Balancing the interplay of histone deacetylases and non-coding genomes: a step closer to understand the landscape of cancer treatment
por: Pu, Jingjing, et al.
Publicado: (2023)

Comment on “Dexamethasone Inhibits Spheroid Formation of Thyroid Cancer Cells Exposed to Simulated Microgravity”
por: Bevelacqua, Joseph J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_icp33nkq2r2qmidocq0ij95gqa